SILAB broadens ingredients offering for dermatological problems
The ingredient, AD-RESYL, is a “patented natural active ingredient dedicated to the comfort and resilience of atopic skin,” according to the company, and comes from its new softcare department.
The ingredient prevents the clinical signs of atopic dermatitis, the company claims, by prolonging remission periods following treatment with corticosteroid therapy.
The supplier claims that the new ingredient is backed by clinical studies, and offers formulators a fully natural raw material: “Tested on cohorts of Caucasian and Asian children and/or adults, AD-RESYL meets the many expectations of patients on the lookout for care and comfort to restore health to their skin: it benefits from clinically demonstrated efficacy, optimum skin tolerance and a controlled natural raw material.”
Backed by research and development
The launch is the first, Silab states, from its team of dedicated researchers looking into natural alternatives for use in products catering to disorders of the skin.
“The new SILAB softcare department is dedicated to the research, production and marketing of innovative natural active ingredients specifically designed to care for dermatological disorders by restoring the homeostasis of healthy skin,” the company explains in a statement.
“It has designed an original scientific research program, comprising innovative in vitro and in vivo models approved by the international dermatological community, to offer a product in the form of a preservative-free powder, revolving around three principles of excellence: Efficacy, Safety and Naturalness.”
Sustainable investment into natural skin care
The company describes the work of its new softcare team as a ‘sustainable investment into the carte of compromised skin’.
“SILAB softcare relies on SILAB's expertise, capacity for innovation and responsive organization to broaden acquired knowledge of healthy skin to the problems of compromised skin,” it notes.
“For over five years, a team of multidisciplinary researchers, made up of molecular biologists, bioinformaticians, clinical experts and process engineers, has been deploying cutting-edge tools and advanced technologies from the healthcare sector to hone its knowledge of cutaneous ecosystems.”
